A consequence of this signaling activity was the oncogenic role of SPCA2 in breast cancer cells, where dysregulation of expression led to constitutive Ca2+ influx, activation of MAP kinase pathways, high rates of proliferation and tumorigenesis. Here, ATP2C2 is linked to breast carcinoma.